Literature DB >> 28315720

The protective effect of the active components of ERPC on diabetic peripheral neuropathy in rats.

Gai-Mei Hao1, Yong-Gang Liu2, Yan Wu3, Wei Xing4, Shu-Zhen Guo5, Yong Wang6, Zheng-Lin Wang7, Chun Li8, Tian-Tian Lv9, Hong-Liang Wang10, Tian-Jiao Shi11, Wei Wang12, Jing Han13.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Euonymus alatus, Radix trichosanthis, Panax notoginseng and Coptis chinensis are popular plants used in traditional Chinese medicine to treat diabetes. AIM OF THE STUDY: The aim of the study is to investigate the therapeutic effect of the active components of Euonymus alatus, Radix trichosanthis, Panax notoginseng and Coptis chinensis (cERPC) on diabetic peripheral neuropathy in the rats and explore the underlying mechanism involved.
METHODS: After diabetes was induced in rats for 20 weeks, cERPC or water was administered for 12 weeks. After a hot plate test, motor nerve conduction velocity and sciatic nerve blood flow were determined; the sciatic nerves were isolated for toluidine blue staining; and the fibre area, fibre diameter, axon area, axon diameter and myelin thickness were evaluated. The levels of the myelin basic protein, myelin protein zero, Oct6 and Krox20 were measured by western blot or immunofluorescence.
RESULTS: cERPC was efficient in reducing the response latency, increasing motor nerve conduction velocity, enhancing sciatic nerve blood flow and ameliorating the pathological changes in diabetic rats. cERPC also had a role in increasing the levels of myelin basic protein and myelin protein zero and improving the expression of Oct6 and Krox20 in sciatic nerves of diabetic rats.
CONCLUSIONS: cERPC ameliorates diabetic peripheral neuropathy by attenuating electrophysiological, circulatory and morphological alterations, which is mediated by the Oct6-Krox20 pathway.
Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Diabetes; Neurodegenerative disorders; Pharmacodynamics; Signal transduction; Traditional Chinese medicine

Mesh:

Substances:

Year:  2017        PMID: 28315720     DOI: 10.1016/j.jep.2017.03.015

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  4 in total

1.  [Approach to creating early diabetic peripheral neuropathy rat model].

Authors:  J He; G H Yuan; J Q Zhang; X H Guo
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-12-18

Review 2.  Antidiabetic Potential of Medicinal Plants and Their Active Components.

Authors:  Bahare Salehi; Athar Ata; Nanjangud V Anil Kumar; Farukh Sharopov; Karina Ramírez-Alarcón; Ana Ruiz-Ortega; Seyed Abdulmajid Ayatollahi; Patrick Valere Tsouh Fokou; Farzad Kobarfard; Zainul Amiruddin Zakaria; Marcello Iriti; Yasaman Taheri; Miquel Martorell; Antoni Sureda; William N Setzer; Alessandra Durazzo; Massimo Lucarini; Antonello Santini; Raffaele Capasso; Elise Adrian Ostrander; Muhammad Iqbal Choudhary; William C Cho; Javad Sharifi-Rad
Journal:  Biomolecules       Date:  2019-09-30

3.  HuoXueJieDu Formula Alleviates Diabetic Retinopathy in Rats by Inhibiting SOCS3-STAT3 and TIMP1-A2M Pathways.

Authors:  Hongliang Wang; Wei Xing; Shijie Tang; Zhenglin Wang; Tiantian Lv; Yan Wu; Shuzhen Guo; Chun Li; Jing Han; Ruixin Zhu; Wei Wang
Journal:  Int J Genomics       Date:  2017-11-29       Impact factor: 2.326

4.  Comprehensive analysis of differentially expressed microRNAs and mRNAs in dorsal root ganglia from streptozotocin-induced diabetic rats.

Authors:  Guojun Guo; Yutian Liu; Sen Ren; Yu Kang; Dominik Duscher; Hans-Günther Machens; Zhenbing Chen
Journal:  PLoS One       Date:  2018-08-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.